期刊
MEDICINAL RESEARCH REVIEWS
卷 41, 期 3, 页码 1499-1538出版社
WILEY
DOI: 10.1002/med.21766
关键词
metabolism; prostate cancer; therapy
资金
- FEDER funds through the POCI-COMPETE 2020 [007491, 029114]
- Foundation for Science and Technology [SFRH/BD/104671/2014, SFRH/BD/111351/2015, UID/Multi/00709/2019]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/111351/2015, UID/Multi/00709/2019, SFRH/BD/104671/2014] Funding Source: FCT
Prostate cancer metabolism is becoming increasingly important, with metabolic reprogramming and activation of specific pathways playing a crucial role in therapy. Glucose, lipids, and glutamine are essential for PCa cell survival and growth.
Prostate cancer (PCa), one of the most commonly diagnosed cancers worldwide, still presents important unmet clinical needs concerning treatment. In the last years, the metabolic reprogramming and the specificities of tumor cells emerged as an exciting field for cancer therapy. The unique features of PCa cells metabolism, and the activation of specific metabolic pathways, propelled the use of metabolic inhibitors for treatment. The present work revises the knowledge of PCa metabolism and the metabolic alterations that underlie the development and progression of the disease. A focus is given to the role of bioenergetic sources, namely, glucose, lipids, and glutamine sustaining PCa cell survival and growth. Moreover, it is described as the action of oncogenes/tumor suppressors and sex steroid hormones in the metabolic reprogramming of PCa. Finally, the status of PCa treatment based on the inhibition of metabolic pathways is presented. Globally, this review updates the landscape of PCa metabolism, highlighting the critical metabolic alterations that could have a clinical and therapeutic interest.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据